157 related articles for article (PubMed ID: 23331756)
1. Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndrome.
Shah RJ; Bellamy SL; Lee JC; Cantu E; Diamond JM; Mangalmurti N; Kawut SM; Ware LB; Christie JD
Am J Transplant; 2013 Mar; 13(3):754-9. PubMed ID: 23331756
[TBL] [Abstract][Full Text] [Related]
2. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
[TBL] [Abstract][Full Text] [Related]
3. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
[TBL] [Abstract][Full Text] [Related]
4. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
[TBL] [Abstract][Full Text] [Related]
5. Blood CD9
Brosseau C; Danger R; Durand M; Durand E; Foureau A; Lacoste P; Tissot A; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Claustre J; Magnan A; Brouard S;
Am J Transplant; 2019 Nov; 19(11):3162-3175. PubMed ID: 31305014
[TBL] [Abstract][Full Text] [Related]
6. Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.
Verleden SE; Vos R; Vandermeulen E; Ruttens D; Bellon H; Heigl T; Van Raemdonck DE; Verleden GM; Lama V; Ross BD; Galbán CJ; Vanaudenaerde BM
Am J Transplant; 2016 Nov; 16(11):3262-3269. PubMed ID: 27367568
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V; Shah PD; Shah A; Weinacker A; Deutschman CS; Kohl BA; Demissie E; Bellamy S; Ware LB;
Am J Respir Crit Care Med; 2009 Nov; 180(10):1010-5. PubMed ID: 19661249
[TBL] [Abstract][Full Text] [Related]
8. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation.
White SR; Floreth T; Liao C; Bhorade SM
PLoS One; 2014; 9(7):e103643. PubMed ID: 25068264
[TBL] [Abstract][Full Text] [Related]
9. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.
Ensor CR; Rihtarchik LC; Morrell MR; Hayanga JW; Lichvar AB; Pilewski JM; Wisniewski S; Johnson BA; D'Cunha J; Zeevi A; McDyer JF
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28008661
[TBL] [Abstract][Full Text] [Related]
10. Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation.
Davis WA; Finlen Copeland CA; Todd JL; Snyder LD; Martissa JA; Palmer SM
Am J Transplant; 2012 Mar; 12(3):745-52. PubMed ID: 22123337
[TBL] [Abstract][Full Text] [Related]
11. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
[TBL] [Abstract][Full Text] [Related]
12. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
[TBL] [Abstract][Full Text] [Related]
13. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
[TBL] [Abstract][Full Text] [Related]
15. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
Hennessy SA; Hranjec T; Swenson BR; Kozower BD; Jones DR; Ailawadi G; Kron IL; Lau CL
Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
[TBL] [Abstract][Full Text] [Related]
16. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
Moore CA; Pilewski JM; Venkataramanan R; Robinson KM; Morrell MR; Wisniewski SR; Zeevi A; McDyer JF; Ensor CR
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273385
[TBL] [Abstract][Full Text] [Related]
17. [Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient].
Yang S; Abuduwufuer A; Lv W; Bao F; Hu J
Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):496-502. PubMed ID: 32517455
[TBL] [Abstract][Full Text] [Related]
18. T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction.
Pain M; Royer PJ; Loy J; Girardeau A; Tissot A; Lacoste P; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Dahan M; Knoop C; Botturi K; Pison C; Danger R; Brouard S; Magnan A;
Am J Transplant; 2017 Jun; 17(6):1502-1514. PubMed ID: 27982503
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
Jaksch P; Taghavi S; Klepetko W; Salama M
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma mannose binding lectin levels are associated with bronchiolitis obliterans after lung transplantation.
Budd SJ; Aris RM; Medaiyese AA; Tilley SL; Neuringer IP
Respir Res; 2012 Jul; 13(1):56. PubMed ID: 22762710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
